Leipzig Startup Unlocks Human Milk's Hidden Compounds for Health and Beauty
Leipzig Startup Unlocks Human Milk's Hidden Compounds for Health and Beauty
Leipzig Startup Unlocks Human Milk's Hidden Compounds for Health and Beauty
A Leipzig-based biotech startup, Primogene, is making strides in producing complex human milk sugars at scale. Using its own proprietary technology, the company creates bioidentical compounds that mirror those naturally found in breast milk. These substances are designed to support health from infancy through to adulthood.
The firm has already attracted funding and industry recognition, positioning itself as a key player in both nutrition and skincare markets.
Primogene specialises in enzymatic processes that produce molecules identical to those in human milk. Their focus lies in human milk oligosaccharides (HMOs), which have potential benefits for premature infants and disease prevention in adults. The company's technology allows for large-scale production of these nutrients, addressing gaps in infant formula and medical nutrition.
Early revenue has come from partnerships and pre-orders, with plans to launch cosmetic ingredients by the end of 2026. While specific product details remain undisclosed, existing collaborations suggest a move into skincare and pharmaceutical applications. The company's approach leverages the same bioidentical molecules to expand into multiple markets.
Support for Primogene has grown through funding from biotech investors, state grants from Saxony, and a third-place win at the 2024 Saxon Founders' Award. The startup has also gained visibility via futureSAX, an innovation platform that connects emerging businesses with industry networks. Saxony's reputation as a hub for cutting-edge solutions has further bolstered the company's development.
Primogene's technology enables the production of health-promoting compounds that closely match natural human biology. With early commercial success and plans to enter the cosmetics market, the company is set to expand its reach. The backing from investors and regional initiatives underscores its potential to deliver science-backed solutions across nutrition and beyond.